Semaglutide is a long-acting GLP-1 receptor agonist widely studied for its powerful effects on appetite regulation, glucose metabolism, and weight management. By mimicking the body’s natural incretin hormones, it enhances insulin secretion, suppresses glucagon release, and slows gastric emptying—supporting improved glycemic control and significant reductions in caloric intake.
Price range: $72.00 through $144.00
For laboratory research use only. Not for human or animal use or consumption. Not a drug, food, dietary supplement, or cosmetic. Not approved by the FDA for any medical use.
Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist designed to replicate and enhance the physiological actions of endogenous GLP-1. It selectively activates GLP-1 receptors in the pancreas, gastrointestinal tract, and central nervous system, producing a multifaceted metabolic response.
Through glucose-dependent stimulation of insulin secretion and suppression of glucagon release, Semaglutide improves glycemic regulation while minimizing the risk of hypoglycemia. Its ability to delay gastric emptying and act on hypothalamic appetite centers results in reduced hunger, increased satiety, and sustained decreases in food intake—making it one of the most extensively researched peptides for metabolic optimization and weight reduction.
Due to its extended half-life, Semaglutide allows for once-weekly administration, supporting consistent receptor activation and stable metabolic effects. Research has demonstrated benefits across multiple domains, including improved insulin sensitivity, reduced visceral adiposity, and enhanced overall metabolic efficiency.
Semaglutide continues to be a cornerstone compound in metabolic and endocrine research, with ongoing studies exploring its broader implications in cardiovascular health, insulin resistance, and long-term weight management strategies.
| Strength | 5mg, 10mg |
|---|
Reviews
There are no reviews yet.